Marc Bosiers1*, MD; Koen Deloose1, MD; Giovanni Torsello2, MD; Dierk Scheinert3, MD; Lieven Maene4, MD; Patrick Peeters5, MD; Stefan Müller-Hülsbeck6, MD; Horst Sievert7, MD; Ralf Langhoff8, MD; Joren Callaert1, MD; Carlo Setacci9, MD; Jeroen Wauters10, MSc
1. Department of Vascular Surgery, A.Z. Sint-Blasius, Dendermonde, Belgium; 2. St. Franziskus-Hospital, Münster, Germany; 3. Klinik und Poliklinik für Angiologie - Universitätsklinikum Leipzig, Leipzig, Germany; 4. Onze Lieve Vrouw Hospital, Aalst, Belgium; 5. Imelda Hospital, Bonheiden, Belgium; 6. Diako Hospital, Flensburg, Germany; 7. CardioVascular Center Frankfurt, Frankfurt, Germany; 8. Sankt Gertrauden-Krankenhaus, Berlin, Germany; 9. University Hospital of Siena, Siena, Italy; 10. Flanders Medical Research Program, Dendermonde, Belgium
Carotid artery stenting (CAS) is associated with a stroke risk, mainly due to dislodgement of debris from the target lesion during the procedure. The stent’s scaffolding capacity plays a major role in preventing procedural events1. The introduction of dual-layer stents might reduce the periprocedural risk of embolisation by extensive plaque coverage and prevention of plaque prolapse.
The CLEAR-ROAD trial evaluated the clinical outcomes of treatment with the Roadsaver carotid artery stent in subjects at high risk for carotid endarterectomy requiring carotid revascularisation due to significant extracranial carotid artery stenosis. This report presents the 12-month outcomes of all 100 included patients.
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
Interventions for strokeCarotid stenting
Read next article
Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: 12-month follow-up results